| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge
|
Greer, Catherine E.
|
|
2007
|
25 |
Supplement 3 |
p. 481-489
9 p.
|
artikel
|
| 2 |
Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice
|
Sun, Jianhua
|
|
2007
|
25 |
Supplement 3 |
p. 1114-1120
7 p.
|
artikel
|
| 3 |
Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges
|
Fogg, Christiana N.
|
|
2007
|
25 |
Supplement 3 |
p. 2787-2799
13 p.
|
artikel
|
| 4 |
Advances in Immunology and Vaccine Discovery
|
Gay, Cyril G.
|
|
2007
|
25 |
Supplement 3 |
p. 7007-7011
5 p.
|
artikel
|
| 5 |
An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses
|
Fournillier, A.
|
|
2007
|
25 |
Supplement 3 |
p. 7339-7353
15 p.
|
artikel
|
| 6 |
A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants
|
Nolan, Terry
|
|
2007
|
25 |
Supplement 3 |
p. 8487-8499
13 p.
|
artikel
|
| 7 |
An overview of acute otitis media in Australian Aboriginal children living in remote communities
|
Morris, P.S.
|
|
2007
|
25 |
Supplement 3 |
p. 2389-2393
5 p.
|
artikel
|
| 8 |
Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up
|
Rendi-Wagner, Pamela
|
|
2007
|
25 |
Supplement 3 |
p. 5097-5101
5 p.
|
artikel
|
| 9 |
Antibody responses after dose-sparing intradermal influenza vaccination
|
Auewarakul, Prasert
|
|
2007
|
25 |
Supplement 3 |
p. 659-663
5 p.
|
artikel
|
| 10 |
Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains
|
Tano, Yoshio
|
|
2007
|
25 |
Supplement 3 |
p. 7041-7046
6 p.
|
artikel
|
| 11 |
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
|
Lyons, Arthur
|
|
2007
|
25 |
Supplement 3 |
p. 3445-3453
9 p.
|
artikel
|
| 12 |
A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide—CRM197 with a meningococcal group C conjugate vaccine in healthy infants: Challenge phase
|
Riddell, Anna
|
|
2007
|
25 |
Supplement 3 |
p. 3906-3912
7 p.
|
artikel
|
| 13 |
A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system
|
Youn, Hyun-Jun
|
|
2007
|
25 |
Supplement 3 |
p. 5189-5198
10 p.
|
artikel
|
| 14 |
Avian and pandemic influenza: An overview
|
Poland, Gregory A.
|
|
2007
|
25 |
Supplement 3 |
p. 3057-3061
5 p.
|
artikel
|
| 15 |
Breastfeeding enhances the antibody response to Hib and Pneumococcal serotype 6B and 14 after vaccination with conjugate vaccines
|
Silfverdal, S.A.
|
|
2007
|
25 |
Supplement 3 |
p. 1497-1502
6 p.
|
artikel
|
| 16 |
Caprine herpesvirus 1 vaccine with the LTK63 mutant as a mucosal adjuvant induces strong protection against genital infection in goats
|
Tempesta, M.
|
|
2007
|
25 |
Supplement 3 |
p. 7927-7930
4 p.
|
artikel
|
| 17 |
Cattle immune response to botulinum type D toxoid: Results of a vaccination study
|
Steinman, A.
|
|
2007
|
25 |
Supplement 3 |
p. 7636-7640
5 p.
|
artikel
|
| 18 |
C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei
|
Bergmann-Leitner, Elke S.
|
|
2007
|
25 |
Supplement 3 |
p. 7732-7736
5 p.
|
artikel
|
| 19 |
Comparative efficacy of an indigenous ‘inactivated vaccine’ using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis ‘Bison type’ with a commercial vaccine for the control of Capri-paratuberculosis in India
|
Singh, S.V.
|
|
2007
|
25 |
Supplement 3 |
p. 7102-7110
9 p.
|
artikel
|
| 20 |
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
|
Belshe, Robert B.
|
|
2007
|
25 |
Supplement 3 |
p. 6755-6763
9 p.
|
artikel
|
| 21 |
Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative study
|
Stephenson, Iain
|
|
2007
|
25 |
Supplement 3 |
p. 4056-4063
8 p.
|
artikel
|
| 22 |
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults
|
McNeil, Shelly A.
|
|
2007
|
25 |
Supplement 3 |
p. 3464-3474
11 p.
|
artikel
|
| 23 |
Compliance and immunogenicity of two hepatitis B vaccination schedules in sex workers in Belgium
|
Wouters, K.
|
|
2007
|
25 |
Supplement 3 |
p. 1893-1900
8 p.
|
artikel
|
| 24 |
Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic
|
Malhotra, Uma
|
|
2007
|
25 |
Supplement 3 |
p. 381-390
10 p.
|
artikel
|
| 25 |
Convincing or confusing?
|
Beutels, Philippe
|
|
2007
|
25 |
Supplement 3 |
p. 1355-1367
13 p.
|
artikel
|
| 26 |
Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3–14 years from the provider and societal perspectives
|
Navas, E.
|
|
2007
|
25 |
Supplement 3 |
p. 3233-3239
7 p.
|
artikel
|
| 27 |
Coxiella burnetii: Host and bacterial responses to infection
|
Waag, David M.
|
|
2007
|
25 |
Supplement 3 |
p. 7288-7295
8 p.
|
artikel
|
| 28 |
CP7_E2alf: A safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV)
|
Koenig, Patricia
|
|
2007
|
25 |
Supplement 3 |
p. 3391-3399
9 p.
|
artikel
|
| 29 |
Dermal testing of vaccines for children at high risk of allergies
|
Sugai, Kazuko
|
|
2007
|
25 |
Supplement 3 |
p. 3454-3463
10 p.
|
artikel
|
| 30 |
Detection of vaccinia virus DNA, but not infectious virus, in the blood of smallpox vaccine recipients
|
Cohen, Jeffrey I.
|
|
2007
|
25 |
Supplement 3 |
p. 4571-4574
4 p.
|
artikel
|
| 31 |
Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people
|
Boot, Hein J.
|
|
2007
|
25 |
Supplement 3 |
p. 4706-4714
9 p.
|
artikel
|
| 32 |
Developing an HPV vaccine to prevent cervical cancer and genital warts
|
Bryan, Janine T.
|
|
2007
|
25 |
Supplement 3 |
p. 3001-3006
6 p.
|
artikel
|
| 33 |
Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: Preparation, characterization and evaluation in guinea pigs
|
Amidi, Maryam
|
|
2007
|
25 |
Supplement 3 |
p. 6818-6829
12 p.
|
artikel
|
| 34 |
DNA vaccines encoding viral envelope proteins confer protective immunity against WSSV in black tiger shrimp
|
Rout, Namita
|
|
2007
|
25 |
Supplement 3 |
p. 2778-2786
9 p.
|
artikel
|
| 35 |
Does pneumococcal vaccine reduce influenza morbidity in humans?
|
Blay, A.
|
|
2007
|
25 |
Supplement 3 |
p. 1071-1075
5 p.
|
artikel
|
| 36 |
Dose–response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost
|
Liu, Jinyan
|
|
2007
|
25 |
Supplement 3 |
p. 2951-2958
8 p.
|
artikel
|
| 37 |
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers
|
Goepfert, Paul A.
|
|
2007
|
25 |
Supplement 3 |
p. 510-518
9 p.
|
artikel
|
| 38 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 39 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 40 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 41 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 42 |
Editorial Board/Aims and Scope
|
|
|
2007
|
25 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 43 |
Editorial Board/Aims and Scope
|
|
|
2007
|
25 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 44 |
Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003
|
Soriano-Gabarró, Montse
|
|
2007
|
25 |
Supplement 3 |
p. A92-A96
nvt p.
|
artikel
|
| 45 |
Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens
|
Uddowla, Sabena
|
|
2007
|
25 |
Supplement 3 |
p. 7984-7993
10 p.
|
artikel
|
| 46 |
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy
|
Kasperska-Zajac, Alicja
|
|
2007
|
25 |
Supplement 3 |
p. 3595-3598
4 p.
|
artikel
|
| 47 |
Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine
|
Zhang, Xiaofei
|
|
2007
|
25 |
Supplement 3 |
p. 3254-3262
9 p.
|
artikel
|
| 48 |
Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques
|
Koraka, Penelopie
|
|
2007
|
25 |
Supplement 3 |
p. 5409-5416
8 p.
|
artikel
|
| 49 |
Epidemiology of invasive Haemophilus influenzae type b disease in Singapore children, 1994–2003
|
Thoon, Koh Cheng
|
|
2007
|
25 |
Supplement 3 |
p. 6482-6489
8 p.
|
artikel
|
| 50 |
Evaluation of combinatorial vaccines against anthrax and plague in a murine model
|
DuBois, Amanda B.
|
|
2007
|
25 |
Supplement 3 |
p. 4747-4754
8 p.
|
artikel
|
| 51 |
Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D
|
Kowalski, Jacek
|
|
2007
|
25 |
Supplement 3 |
p. 2296-2305
10 p.
|
artikel
|
| 52 |
Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy
|
Rossi, Renato E.
|
|
2007
|
25 |
Supplement 3 |
p. 957-964
8 p.
|
artikel
|
| 53 |
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients
|
Schlaphoff, Verena
|
|
2007
|
25 |
Supplement 3 |
p. 6793-6806
14 p.
|
artikel
|
| 54 |
Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children
|
Heeg, Christiane
|
|
2007
|
25 |
Supplement 3 |
p. 1030-1035
6 p.
|
artikel
|
| 55 |
Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: The Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3
|
Osborne, John D.
|
|
2007
|
25 |
Supplement 3 |
p. 8807-8832
26 p.
|
artikel
|
| 56 |
HBV serological markers of vaccinated children in remote areas of Taiwan: Emphasis on factors contributing to vaccine failure
|
Huang, Mei-Liang
|
|
2007
|
25 |
Supplement 3 |
p. 6326-6333
8 p.
|
artikel
|
| 57 |
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
|
Stamataki, Zania
|
|
2007
|
25 |
Supplement 3 |
p. 7773-7784
12 p.
|
artikel
|
| 58 |
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
|
Haber, Michael
|
|
2007
|
25 |
Supplement 3 |
p. 5390-5398
9 p.
|
artikel
|
| 59 |
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant
|
Mbawuike, I.
|
|
2007
|
25 |
Supplement 3 |
p. 3263-3269
7 p.
|
artikel
|
| 60 |
Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
|
Barreto, L.
|
|
2007
|
25 |
Supplement 3 |
p. 8172-8179
8 p.
|
artikel
|
| 61 |
Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine
|
Seo, Sang-Uk
|
|
2007
|
25 |
Supplement 3 |
p. 8067-8076
10 p.
|
artikel
|
| 62 |
Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine
|
Hepburn, Matthew J.
|
|
2007
|
25 |
Supplement 3 |
p. 6089-6097
9 p.
|
artikel
|
| 63 |
Immunization coverage and its determinants in children aged 12–23 months in Gansu, China
|
Cui, Fu-Qiang
|
|
2007
|
25 |
Supplement 3 |
p. 664-671
8 p.
|
artikel
|
| 64 |
Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies
|
Quiambao, Beatriz P.
|
|
2007
|
25 |
Supplement 3 |
p. 4470-4477
8 p.
|
artikel
|
| 65 |
Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium
|
Costa, Wagner A.
|
|
2007
|
25 |
Supplement 3 |
p. 8140-8145
6 p.
|
artikel
|
| 66 |
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
|
van den Dobbelsteen, Germie P.J.M.
|
|
2007
|
25 |
Supplement 3 |
p. 2491-2496
6 p.
|
artikel
|
| 67 |
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants
|
Esposito, Susanna
|
|
2007
|
25 |
Supplement 3 |
p. 4889-4894
6 p.
|
artikel
|
| 68 |
IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study
|
Brignone, Chrystelle
|
|
2007
|
25 |
Supplement 3 |
p. 4641-4650
10 p.
|
artikel
|
| 69 |
Increased potency of BioThrax® anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109
|
Gu, Mili
|
|
2007
|
25 |
Supplement 3 |
p. 526-534
9 p.
|
artikel
|
| 70 |
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
|
Olsson, Sven-Eric
|
|
2007
|
25 |
Supplement 3 |
p. 4931-4939
9 p.
|
artikel
|
| 71 |
Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine
|
Lloyd, Megan L.
|
|
2007
|
25 |
Supplement 3 |
p. 679-690
12 p.
|
artikel
|
| 72 |
Investigation of mumps vaccine failures in Minsk, Belarus, 2001–2003
|
Atrasheuskaya, Alena V.
|
|
2007
|
25 |
Supplement 3 |
p. 4651-4658
8 p.
|
artikel
|
| 73 |
Kinetics of the immune response following pneumococcal PD conjugate vaccination
|
Schuerman, Lode
|
|
2007
|
25 |
Supplement 3 |
p. 1953-1961
9 p.
|
artikel
|
| 74 |
Long lasting BCG protection against leprosy
|
Rodrigues, Laura Cunha
|
|
2007
|
25 |
Supplement 3 |
p. 6842-6844
3 p.
|
artikel
|
| 75 |
Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants
|
Jin, Liang
|
|
2007
|
25 |
Supplement 3 |
p. 2043-2050
8 p.
|
artikel
|
| 76 |
Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life
|
Guiso, N.
|
|
2007
|
25 |
Supplement 3 |
p. 1390-1397
8 p.
|
artikel
|
| 77 |
Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma
|
Zuccotti, Gianvincenzo
|
|
2007
|
25 |
Supplement 3 |
p. 6692-6698
7 p.
|
artikel
|
| 78 |
Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins
|
Cavanagh, Dave
|
|
2007
|
25 |
Supplement 3 |
p. 5558-5562
5 p.
|
artikel
|
| 79 |
Modulation of the infant immune responses by the first pertussis vaccine administrations
|
Mascart, F.
|
|
2007
|
25 |
Supplement 3 |
p. 391-398
8 p.
|
artikel
|
| 80 |
Molecular adjuvant C3d3 improved the anti-hCGβ humoral immune response in vaginal inoculation with live recombinant Lactobacillus expressing hCGβ-C3d3 fusion protein
|
Yao, Xiao-Ying
|
|
2007
|
25 |
Supplement 3 |
p. 6129-6139
11 p.
|
artikel
|
| 81 |
Monitoring temperatures in the vaccine cold chain in Bolivia
|
Nelson, Carib
|
|
2007
|
25 |
Supplement 3 |
p. 433-437
5 p.
|
artikel
|
| 82 |
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists
|
Welters, Marij J.P.
|
|
2007
|
25 |
Supplement 3 |
p. 1379-1389
11 p.
|
artikel
|
| 83 |
Novel marker vaccines against classical swine fever
|
Beer, Martin
|
|
2007
|
25 |
Supplement 3 |
p. 5665-5670
6 p.
|
artikel
|
| 84 |
Pathophysiology of white-tailed deer vaccinated with porcine zona pellucida immunocontraceptive
|
Curtis, Paul D.
|
|
2007
|
25 |
Supplement 3 |
p. 4623-4630
8 p.
|
artikel
|
| 85 |
Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population
|
Rendi-Wagner, Pamela
|
|
2007
|
25 |
Supplement 3 |
p. 927-931
5 p.
|
artikel
|
| 86 |
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
|
Halperin, Scott A.
|
|
2007
|
25 |
Supplement 3 |
p. 450-457
8 p.
|
artikel
|
| 87 |
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
|
Stoute, José A.
|
|
2007
|
25 |
Supplement 3 |
p. 176-184
9 p.
|
artikel
|
| 88 |
Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S.
|
Kulasingam, Shalini L.
|
|
2007
|
25 |
Supplement 3 |
p. 8110-8113
4 p.
|
artikel
|
| 89 |
Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease
|
Hsieh, Ming Kun
|
|
2007
|
25 |
Supplement 3 |
p. 5417-5427
11 p.
|
artikel
|
| 90 |
Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain
|
Martelli, Paolo
|
|
2007
|
25 |
Supplement 3 |
p. 3400-3408
9 p.
|
artikel
|
| 91 |
Protective efficacy of neutralizing antibodies against Ebola virus infection
|
Takada, Ayato
|
|
2007
|
25 |
Supplement 3 |
p. 993-999
7 p.
|
artikel
|
| 92 |
Radiology quality assurance in a developing country setting: The 11-valent pneumococcal conjugate vaccine trial, Bohol, Philippines
|
Arcay, Jose D.
|
|
2007
|
25 |
Supplement 3 |
p. 2528-2532
5 p.
|
artikel
|
| 93 |
Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine
|
Smets, F.
|
|
2007
|
25 |
Supplement 3 |
p. 5278-5282
5 p.
|
artikel
|
| 94 |
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program
|
|
|
2007
|
25 |
Supplement 3 |
p. 3118-3123
6 p.
|
artikel
|
| 95 |
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
|
Du, Lanying
|
|
2007
|
25 |
Supplement 3 |
p. 2832-2838
7 p.
|
artikel
|
| 96 |
Recombinant capripoxviruses expressing proteins of bluetongue virus: Evaluation of immune responses and protection in small ruminants
|
Perrin, Aurélie
|
|
2007
|
25 |
Supplement 3 |
p. 6774-6783
10 p.
|
artikel
|
| 97 |
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates
|
Nolan, Sheila M.
|
|
2007
|
25 |
Supplement 3 |
p. 6409-6422
14 p.
|
artikel
|
| 98 |
Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine
|
Howie, Stephen R.C.
|
|
2007
|
25 |
Supplement 3 |
p. 6305-6309
5 p.
|
artikel
|
| 99 |
Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults
|
Macaladad, N.
|
|
2007
|
25 |
Supplement 3 |
p. 2139-2144
6 p.
|
artikel
|
| 100 |
Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa
|
Sirima, Sodiomon B.
|
|
2007
|
25 |
Supplement 3 |
p. 2723-2732
10 p.
|
artikel
|
| 101 |
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
|
Kshirsagar, Nilima
|
|
2007
|
25 |
Supplement 3 |
p. A101-A107
nvt p.
|
artikel
|
| 102 |
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals
|
Parrino, Janie
|
|
2007
|
25 |
Supplement 3 |
p. 1513-1525
13 p.
|
artikel
|
| 103 |
Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia
|
Aseffa, Abraham
|
|
2007
|
25 |
Supplement 3 |
p. A79-A82
nvt p.
|
artikel
|
| 104 |
Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005
|
Dobardzic, Azra
|
|
2007
|
25 |
Supplement 3 |
p. 4244-4251
8 p.
|
artikel
|
| 105 |
Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies
|
Rezaei, Nima
|
|
2007
|
25 |
Supplement 3 |
p. 5308-5314
7 p.
|
artikel
|
| 106 |
Short-term endocrine and metabolic reactions before and after second immunization against GnRH in boars
|
Claus, Rolf
|
|
2007
|
25 |
Supplement 3 |
p. 4689-4696
8 p.
|
artikel
|
| 107 |
Study of the serological response after vaccination against tick-borne encephalitis in Sweden
|
Vene, Sirkka
|
|
2007
|
25 |
Supplement 3 |
p. 366-372
7 p.
|
artikel
|
| 108 |
Survey of poliovirus antibodies during the final stage of polio eradication in Egypt
|
El-Sayed, Nasr
|
|
2007
|
25 |
Supplement 3 |
p. 5062-5070
9 p.
|
artikel
|
| 109 |
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
|
Ebensen, Thomas
|
|
2007
|
25 |
Supplement 3 |
p. 1464-1469
6 p.
|
artikel
|
| 110 |
The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection
|
Kojima, Yoshitsugu
|
|
2007
|
25 |
Supplement 3 |
p. 438-445
8 p.
|
artikel
|
| 111 |
The epidemiology and burden of rotavirus in China: A review of the literature from 1983 to 2005
|
Orenstein, Evan W.
|
|
2007
|
25 |
Supplement 3 |
p. 406-413
8 p.
|
artikel
|
| 112 |
The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents
|
Ortega-Barrìa, Eduardo
|
|
2007
|
25 |
Supplement 3 |
p. 8432-8440
9 p.
|
artikel
|
| 113 |
The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine
|
Lininger, Linda A.
|
|
2007
|
25 |
Supplement 3 |
p. 1619-1625
7 p.
|
artikel
|
| 114 |
The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity
|
Park, Mi-Young
|
|
2007
|
25 |
Supplement 3 |
p. 7322-7330
9 p.
|
artikel
|
| 115 |
The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken
|
Dilaveris, Dimitrios
|
|
2007
|
25 |
Supplement 3 |
p. 3792-3799
8 p.
|
artikel
|
| 116 |
The Sb14-3-3ζ recombinant protein protects against Schistosoma bovis in BALB/c mice
|
Uribe, N.
|
|
2007
|
25 |
Supplement 3 |
p. 4533-4539
7 p.
|
artikel
|
| 117 |
The Schistosoma bovis Sb14-3-3ζ recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice
|
Siles-Lucas, M.
|
|
2007
|
25 |
Supplement 3 |
p. 7217-7223
7 p.
|
artikel
|
| 118 |
The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach
|
Bos, J.M.
|
|
2007
|
25 |
Supplement 3 |
p. 6922-6929
8 p.
|
artikel
|
| 119 |
Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule
|
Schöndorf, I.
|
|
2007
|
25 |
Supplement 3 |
p. 1470-1475
6 p.
|
artikel
|
| 120 |
Typhoid fever vaccines: Systematic review and meta-analysis of randomised controlled trials
|
Fraser, Abigail
|
|
2007
|
25 |
Supplement 3 |
p. 7848-7857
10 p.
|
artikel
|
| 121 |
Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis
|
De Wals, Philippe
|
|
2007
|
25 |
Supplement 3 |
p. 5433-5440
8 p.
|
artikel
|
| 122 |
Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain)
|
Borràs, E.
|
|
2007
|
25 |
Supplement 3 |
p. 3240-3243
4 p.
|
artikel
|
| 123 |
Vaccination of chickens against Campylobacter
|
de Zoete, Marcel R.
|
|
2007
|
25 |
Supplement 3 |
p. 5548-5557
10 p.
|
artikel
|
| 124 |
Vaccination responses and lymphocyte subsets after autologous stem cell transplantation
|
van der Velden, A.M.T.
|
|
2007
|
25 |
Supplement 3 |
p. 8512-8517
6 p.
|
artikel
|
| 125 |
Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3
|
Saini, Manisha
|
|
2007
|
25 |
Supplement 3 |
p. 8660-8663
4 p.
|
artikel
|
| 126 |
Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses
|
Fine, Donald L.
|
|
2007
|
25 |
Supplement 3 |
p. 1868-1876
9 p.
|
artikel
|
| 127 |
Viral antigen production in cell cultures on microcarriers
|
Conceição, M.M.
|
|
2007
|
25 |
Supplement 3 |
p. 7785-7795
11 p.
|
artikel
|
| 128 |
Viral vectored immunocontraception: Screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector
|
Redwood, Alec J.
|
|
2007
|
25 |
Supplement 3 |
p. 698-708
11 p.
|
artikel
|
| 129 |
What needs to be done for polio eradication in India?
|
Paul, Yash
|
|
2007
|
25 |
Supplement 3 |
p. 6431-6436
6 p.
|
artikel
|
| 130 |
WHO Working Group on standardisation and control of acellular pertussis vaccines—Report of a meeting held on 16–17 March 2006, St. Albans, United Kingdom
|
Xing, D.K.L.
|
|
2007
|
25 |
Supplement 3 |
p. 2749-2757
9 p.
|
artikel
|
| 131 |
Widening inequalities in MMR vaccine uptake rates among ethnic groups in an urban area of the UK during a period of vaccine controversy (1994–2000)
|
Hawker, Jeremy I.
|
|
2007
|
25 |
Supplement 3 |
p. 7516-7519
4 p.
|
artikel
|
| 132 |
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9–11 March 2005
|
Alonso, Jean Michel
|
|
2007
|
25 |
Supplement 3 |
p. 4125-4129
5 p.
|
artikel
|
Tijdschrift beschrijving